RETLIRA is a powerful triple-action peptide therapy containing 30mg of new-generation weight loss compound targeting:
GLP-1 receptors – reduces appetite and stabilizes blood sugar
GIP receptors – improves insulin sensitivity
Glucagon receptors – boosts fat burning and metabolism
RETLIRA mimics three key metabolic hormones in one weekly injection,
outperforming older GLP-1 options.
High-strength – clinically backed for fat loss & amp; glucose control
Convenient pre-filled 30mg pen
Ideal for those who’ve plateaued on Single or Dual agonists.
Supports long-term appetite regulation, visceral fat loss and insulin
improvement
Used in cutting-edge obesity protocols
Triple action. One injection. Total transformation.
Dosing Adjustable dial, 2.5mg–7.5mg per week
Injection Type Subcutaneous (abdomen, thigh, upper arm)
Use Once per week
Storage: Refrigerate after use at (2–8°C). 
Format: Prefilled, dial-dose pen (multi-week use)
One pen lasts 7 to 12 weeks, depending on dosage. Use once weekly on the same day each week.
Suggested Dosing Protocol
Week 1–2  2.5mg    Intro phase – reduce nausea
Week 3-4  3.5mg    Appetite control begins
Week 5-6  5.0mg    Fat burn stage
Week 7 onwards    7.5mg -  Full therapeutic level
Box contains:        1 Pen and 8 Disposable Needles.